NKGen Biotech Inc. (OTC:NKGN) Financings

NKGen Biotech Inc.

Financings

RaiseDate
Funding (terms to be finalized)
Closed: US$17M raised
Buyers: AlpineBrook Capital GP 1 Limited (provided the majority of the $17 million funding); Dr. Paul Y. Song (provided the remainder of the funding)
Insiders: NKGen CEO Dr. Paul Y. Song provided part of the funding alongside AlpineBrook
Use of proceeds: Purchase of NKMax Co., Ltd. shares
Sep 9, 2025
Private placement of shares of common stock and warrants
Closed: US$2M raised · US$0.25 a share
Buyers: Japanese strategic investor ($2 million)
Use of proceeds: Resources to regain compliance with reporting obligations and listing standards
Jul 16, 2025
Private placement of shares of common stock and warrants
Closed: US$2.65M raised
Buyers: Paul Y. Song, M.D. ($2.65 million in shares of common stock and warrants)
Insiders: Chairman & CEO Paul Y. Song, M.D. invested $2.65 million cash in shares of common stock and warrants
Use of proceeds: Accelerate Phase 2 Alzheimer's trial, reduce payables, general working capital and public company compliance expenses
May 8, 2025

Read by 6ix AI from the company's releases